Cutaneous mucormycosis.
Jean-Baptiste VulstekeDries DeerenPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
Mucormycosis is an aggressive invasive fungal infection that occurs rarely in immunocompetent but frequently in immunocompromised patients. We present a case of a 68-year-old patient with cutaneous mucormycosis due to Rhizopus pusillus. He was initially hospitalized for invasive pulmonary aspergillosis and diabetes mellitus secondary to acute graft-versus-host treatment with glucocorticoids after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. Treatment with liposomal amphotericin B and posaconazole was initiated but the patient developed septic shock with multiple organ failure and died 5 days later. The risk factors, clinical presentation, treatment, and prognosis of cutaneous mucormycosis in hematopoietic stem cell and solid organ transplant patients are discussed.
Keyphrases
- acute myeloid leukemia
- end stage renal disease
- allogeneic hematopoietic stem cell transplantation
- risk factors
- newly diagnosed
- ejection fraction
- chronic kidney disease
- septic shock
- peritoneal dialysis
- acute lymphoblastic leukemia
- type diabetes
- case report
- hematopoietic stem cell
- skeletal muscle
- metabolic syndrome
- patient reported outcomes
- intensive care unit
- liver failure
- insulin resistance
- drug induced